Compass Financial Management LLC Buys Shares of 3,098 Humana Inc. $HUM

Compass Financial Management LLC purchased a new position in Humana Inc. (NYSE:HUMFree Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 3,098 shares of the insurance provider’s stock, valued at approximately $1,229,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Wilkerson Advisory Group LLC grew its position in Humana by 24.6% in the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after acquiring an additional 33 shares in the last quarter. Bogart Wealth LLC increased its stake in Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Fiduciary Alliance LLC raised its position in Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after purchasing an additional 49 shares in the last quarter. Sanctuary Advisors LLC raised its position in Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after purchasing an additional 52 shares in the last quarter. Finally, Horizon Investments LLC lifted its stake in Humana by 2.5% during the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after purchasing an additional 55 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on HUM. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. UBS Group began coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. TD Cowen increased their price target on shares of Humana from $350.00 to $370.00 and gave the company a “hold” rating in a research report on Friday, July 31st. Finally, Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target on the stock in a research note on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $395.22.

Check Out Our Latest Analysis on Humana

Humana Price Performance

Shares of Humana stock opened at $379.22 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The business’s 50 day simple moving average is $383.38 and its two-hundred day simple moving average is $282.25. The stock has a market capitalization of $45.54 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 2.17 and a beta of 0.72.

Humana (NYSE:HUMGet Free Report) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the prior year, the firm posted $6.27 earnings per share. The business’s quarterly revenue was up 26.2% compared to the same quarter last year. Analysts forecast that Humana Inc. will post 9.08 EPS for the current year.

Humana Company Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.